Invitae, a diagnostics company in San Francisco, has scored the first big biotech IPO of the year. The firm priced 6.35 million shares of its stock at $16 per share to raise nearly $102 million.
The firm is led by CEO Randy Scott (pictured), the former CEO of another Bay Area diagnostics firm, Genomic Health. Scott spun Invitae out of Genomic Health in 2012, with assets from another company as well, with the ambitious goal to “aggregate all the world’s genetic tests into a single assay, for less than the cost of a single assay today,” Scott told Xconomy in 2013.
As the largest generation in American history transitions toward traditional retirement ages, what effect will it have on entrepreneurship?
Will Baby Boomers continue to start businesses into their 70s and 80s?
Will Boomer entrepreneurs transition their businesses to the next generation?
Where and how will they deploy their wealth in support of new entrepreneurship?
In 2014, the oldest of the Boomers turned 68; the youngest turned 50. They will continue to heavily influence the pace of business creation in the United States over the next decade.
Developing countries in Africa have been hit by the full force of the recent Swiss Leaks scandal. The Swiss branch of HSBC bank cost Tanzania, Senegal and the Ivory Coast over 30% of their national health budgets. EurActiv France reports.
Fourteen years ago, during the darkest moments of the “stem-cell wars” pitting American scientists against the White House of George W. Bush, one group of advocates could be counted on to urge research using cells from human embryos: parents of children with type 1 diabetes. Motivated by scientists who told them these cells would lead to amazing cures, they spent millions on TV ads, lobbying, and countless phone calls to Congress.
The recent February issue of Health Affairs, which features a series of articles on innovation, provides us with an opportunity to examine the state of America’s innovation ecosystem for medical technology. This ecosystem has produced a myriad of medical advances, ranging from advanced imaging to molecular diagnostics, minimally invasive surgical tools, and incredibly sophisticated implants. These technologies have shortened hospital stays, reduced the economic burden of disease, and saved and improved millions of lives.
Ana Pastor disfrutó ayer de un día de gloría con la espectacular salida a bolsa de Aena tras una privatización que despegó con turbulencias. Ahora cruza los dedos para resolver otro de los grandes conflictos que afectan a la Marca España: las obras del AVE entre las ciudades árabes de LaMeca y Medina. Hoy, los responsables del consorcio español se reúnen de urgencia en París para preparar la estrategia con la que evitar que Gobierno de Arabia Saudí les quite un contrato de 6.700 millones.
El pasado miércoles el Eustat hacía públicos los datos de inversión en I+D correspondientes a 2013, planteando los mismos, por inusuales, algunas reflexiones.
om a small start-up just a few weeks ago, Israel’s EGM (Electric Grid Management) is now part of a huge conglomerate – and its technology could help hundreds of millions of people in the US and around the world. A graduate of the IBM Alpha Zone Accelerator’s recently-completed first round, EGM is now part of IBM’s Insights Foundation for Energy solution, an electrical grid management and analytics program that will be offered to electricity utilities as part of IBM’s substantial infrastructure management business.
In a small-but-significant addition to its budding interest in robotics, San Diego-based Qualcomm (NASDAQ: QCOM) has acquired KMel Robotics, a Philadelphia, PA-based startup that specializes in multi-rotor drones capable of coordinated, high-performance operations.
Financial terms of the deal have not been disclosed.
